Top Story

How California is Dominating the Cannabis Brand Landscape
February 24th, 2021 - Ryan Allway
California is well known for its brand dominance—from its Hollywood studios to its Napa Valley wines. As a tastemaker across industries, the state’s cannabis brands are we...
Top News

Psychedelic Wellness-Focused Company, Delic Holdings, to Acquire Complex Biotech Discovery Ventures Ltd.
February 25th, 2021 - Ryan Allway

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
February 24th, 2021 - Ryan Allway

There’s no Magic Answer to the Question, “Can I Patent Magic Mushrooms?”
February 24th, 2021 - Ryan Allway
Public Companies
Private Companies & Entrepreneurs
Cannabis & CBD

Verano Holdings Announces C$100 Million Bought Deal Private Placement of Special Warrants
February 25th, 2021 - Ryan Allway

IM Cannabis Common Shares Expected to Begin Trading on NASDAQ on March 1, 2021
February 25th, 2021 - Ryan Allway

Coda Signature Announces Funding Round to Support Growth
February 25th, 2021 - Ryan Allway

Cannabix Technologies Develops Version 3.0 of THC Breath Analyzer Device
February 25th, 2021 - Ryan Allway

Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
February 25th, 2021 - Ryan Allway

Acreage Announces Sale of Florida Operations To Red White & Bloom Brands
February 25th, 2021 - Ryan Allway

Liberty Health Sciences Shareholders Overwhelmingly Approve Acquisition by Ayr Wellness
February 24th, 2021 - Ryan Allway

Australis Completes Definitive Agreement to Acquire 51% Stake in ALPS
February 24th, 2021 - Ryan Allway

Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
February 24th, 2021 - Ryan Allway
Psychedelics & Mushrooms

PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange
February 25th, 2021 - Ryan Allway

Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil
February 25th, 2021 - Ryan Allway
Nova Mentis Autism Clinical Study Approved by Institutional Review Board
February 25th, 2021 - Ryan Allway

Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness
February 25th, 2021 - Ryan Allway

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
February 25th, 2021 - Ryan Allway

PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy
February 25th, 2021 - Ryan Allway

Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
February 25th, 2021 - Ryan Allway

Psychedelic Wellness-Focused Company, Delic Holdings, to Acquire Complex Biotech Discovery Ventures Ltd.
February 25th, 2021 - Ryan Allway

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
February 24th, 2021 - Ryan Allway
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer